Encision Inc. | ||||
Unaudited Condensed Statements of Cash Flows | ||||
(in thousands) | ||||
Years Ended | ||||
March 31, 2019 | March 31, 2018 | |||
Operating activities: | ||||
Net income (loss) | $ (236) | $ 336 | ||
Adjustments to reconcile net income (loss) to cash
generated by operating activities: | ||||
Depreciation and amortization | 182 | 203 | ||
Share-based compensation expense | 37 | 66 | ||
(Recovery from) provision for doubtful accounts, net | 6 | (13) | ||
(Recovery from) inventory obsolescence, net | 29 | (29) | ||
Changes in operating assets and liabilities: | ||||
Accounts receivable | (52) | 92 | ||
Inventories | (64) | (280) | ||
Prepaid expenses and other assets | (56) | (15) | ||
Accounts payable | 111 | 64 | ||
Accrued compensation and other accrued liabilities | (85) | (4) | ||
Net cash generated by operating activities | (128) | 420 | ||
Investing activities: | ||||
Acquisition of property and equipment | (55) | (57) | ||
Patent costs | (6) | (43) | ||
Net cash (used in) investing activities | (61) | (100) | ||
Financing activities: | ||||
Paydown of credit facility, net change | –– | (275) | ||
Net proceeds from the issuance of common stock | 347 | 25 | ||
Net cash generated by (used in) financing activities | 347 | (250) | ||
Net increase in cash, cash equivalents and restricted cash | 158 | 70 | ||
Cash, cash equivalents and restricted cash, beginning of period | 140 | 45 | ||
Cash, cash equivalents and restricted cash, end of period | $ 298 | $ 115 | ||
